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ABSTRACT
Objective: The study’s purpose has been to assess both clinical and immunological characteristics of renal 
transplant recipients. Methods: It is a documentary and retrospective study that was performed at the renal 
transplantation ambulatory from the Hospital Geral de Fortaleza (HGF), Fortaleza city, Ceará State, with 
patients hospitalized from June 2012 to June 2014. The sample consisted of 300 patients submitted to renal 
transplantation. The predictive variables of interest were subdivided in the following categories: pre-transplant 
characteristics, post-transplant characteristics and immunological characteristics. Pearson and Spearman 
tests were used to evaluate the correlation between variables. Results: There was a predominance of male 
patients (65%), with ages ranging from 44 to 56 years (31.4%). A statistically significant relationship was found 
between the Donor-Specific Antibody and Delayed Graft Function (p<0.04), Cellular Rejection and Panel-
Reactive Antibody class I (p<0.05), duration of hospitalization and Delayed Graft Function (p<0.001) and 
also between the Human Leukocyte Antigen and MISMATCH. Conclusion: It is pointed out the need for a 
critical and individualized follow-up of the transplanted patient by the professionals to guarantee the long-term 
transplantation success. 
Descriptors: Assessment, kidney transplantation, Nursing.
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RESUMO
Objetivo: Avaliar as características clínicas e imunológica dos receptores de 
transplante renal. Métodos: estudo documental e retrospectivo, realizado 
em um Ambulatório do Hospital Geral de Fortaleza, Fortaleza, Ceará, Brasil, 
com pacientes internados no período de junho de 2012 a junho de 2014. A 
amostra foi composta por 300 pacientes submetidos ao transplante renal. As 
variáveis preditoras de interesse, foram subdivididas em: características pré-
transplante, características pós-transplante e características imunológicas. 
Utilizou-se testes de Pearson e Spearman para avaliar correlação entre 
variáveis. Resultados: Houve predomínio de pacientes do sexo masculino 
(65%), com faixa etária entre 44 e 56 anos (31,4%). Demonstrou-se relação 
estatisticamente significante entre o DSA e a disfunção do enxerto (p<0,04), 
Rejeição celular o Painel Reativo classe I (p< 0,05), o tempo de internação e 
a disfunção do enxerto (p<0,001) e entre o entre o HLA e o MISMATCH. 
Conclusão: Aponta-se a necessidade de um acompanhamento crítico e 
individualizado do paciente transplantado por parte dos profissionais para 
garantir o sucesso do transplante a longo prazo.    
Descritores: Avaliação, Transplante de Rim, Enfermagem.
RESUMEN
Objetivo: Evaluar las características clínicas e inmunológicas de los 
receptores de trasplante renal. Métodos: estudio documental y retrospectivo 
realizado en una clínica del Hospital General de Fortaleza, Fortaleza, 
Ceará, Brasil, con pacientes ingresados desde junio de 2012 a junio de 
2014. La muestra fue de 300 pacientes sometidos a trasplante de riñón. Las 
variables predictoras de interés, fueron subdivididas en: características pre-
trasplante, características post-transplante y características inmunológicas. 
Se utilizaron pruebas de Pearson y Spearman para evaluar la correlación 
entre variables. Resultados: Hubo un predominio de pacientes del sexo 
masculino (65%), con edades comprendidas entre 44 y 56 años (31,4%). 
Se demostró una relación estadísticamente significativa entre el DSA y la 
disfunción del injerto (p <0,04), el rechazo celular del panel reactivo clase 
I (p <0,05), el tiempo de internación y la disfunción del injerto (p <0,001) 
y entre el HLA y el MISMATCH. Conclusión: Se apunta la necesidad de 
un acompañamiento crítico e individualizado del paciente trasplantado por 
parte de los profesionales para garantizar el éxito del trasplante a largo plazo.
Descriptores: Evaluación, Trasplante de Riñón, Enfermeria.
INTRODUCTION
Transplantation consists of a surgical procedure in which 
an organ or tissue is transferred from one individual to 
another, in order to replace or compensate for a lost function. 
In kidney transplantation, a healthy kidney is implanted in 
a person with chronic end-stage renal disease as the most 
effective replacement therapy.1
According to the National Transplant Registry in the 
first quarter of 2015 compared to the data for 2014, there 
was a reduction in the number of transplants, registering 
a drop of 1.4% of potential donors and 0.8% of effective 
donors. Kidney transplantation fell by 7.6%, with a drop of 
20.3% in live donors, and 3.4% in deceased donors. About 
40% of families refuse to be organ donors.2
Renal transplantation is seen as an inducing process of 
intense inflammatory reaction where the transplanted organ 
functions as a foreign body in the recipient’s organism, 
filled with immunogenic antigens that are presented to 
their complex immune system, always determining an 
immunity reaction.3
After transplantation, the huge challenge is to avoid 
complications that could compromise the functioning of 
the graft and lead to its loss, especially rejection leading to 
a decline in renal function and requiring rapid intervention 
to avoid transplant failure.
Graft rejections are immunological processes that can be 
classified into cellular and humoral. In cellular rejections are 
generally acute and T lymphocytes are the main mediators 
of graft damage. In humoral rejections, the graft is assaulted 
by Donor-Specific Antibody (DSA) against donor antigens, 
produced by the recipient. These DSAs can also be produced 
later in life after transplantation, and thus rejection occurs 
progressively and chronically, culminating with a new 
chronic kidney disease.4-6
In order for renal transplantation success to occur, 
there must be ABO blood group compatibility, a Human 
Leukocyte Antigen (HLA) histocompatibility typing, and 
Crossmatch recognition, which is capable of predicting 
hyperacute rejection episodes.1
Another factor that has substantially contributed to the 
fact that kidney transplantation is considered the best option 
for patients with chronic kidney disease is the technological 
advance with regard to immunosuppressive therapy. The 
main purpose of this therapy is to increase graft survival, 
avoiding acute and chronic rejections of the transplanted 
organ.7,8 With the advent of new immunosuppressive drugs, 
acute rejection rates decreased significantly, although the 
impact on the graft half-life has been less important.9
Renal graft monitoring is currently performed by 
measuring its function, and blood creatinine, whose 
variations are not specific for rejection, and renal biopsy 
are routinely determined. Hence, the identification of 
molecules by non-invasive, sensitive methods, useful in 
clinical practice, so-called biomarkers, has been the object 
of extensive studies by several groups of researchers.10
The nurses’ contribution to the success of transplantation 
is undeniable since it provides specialized care in the 
protection, promotion, and rehabilitation of the health of 
candidates, recipients and their families, as well as of living 
and family donors throughout the life cycle.11
Bearing in mind this framework, the study aimed to 
assess both clinical and immunological characteristics of 
renal transplant recipients.
METHODS
It is a documentary and retrospective study that was 
performed at the renal transplantation ambulatory from 
the Hospital Geral de Fortaleza (HGF), Fortaleza city, Ceará 
State, with patients hospitalized from June 2012 to June 
2014. It is a tertiary public hospital of reference in the 
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whole s Ceará State regarding the execution of transplanta-
tion of kidney, pancreas, liver, and corneas. The justification 
of this temporal cut is due to the access to complete data 
for the analysis of graft function.
The sample consisted of 300 patients submitted to renal 
transplantation. The data were collected from July to Octo-
ber 2016, using a form, based on the data recorded on 
the medical records of transplanted patients, regardless 
of gender or donor type. Children and double transplants 
were excluded from the study since their physiology and 
hemodynamics differ from adults and elderly people. The 
form contained sociodemographic data, clinical and labo-
ratory aspects of transplant recipients.
The data were organized using the Excel program and 
then transferred to the Statistical Package for Social Scien-
ces (SPSS) program version 21.0. Pearson’s tests (the corre-
lation between hospitalization time and graft dysfunction 
rate, the correlation between cellular rejection and panel-
-reactive antibody class I and class II, and the correlation 
between humoral rejection and panel-reactive antibody 
class I and class II) and Spearman (Correlation between 
DSA and graft dysfunction) for data analysis. Concerning 
the predictive variables of interest, they were subdivided 
in the following categories: pre-transplant characteristics, 
post-transplant characteristics, and immunological cha-
racteristics.
The study was carried out in agreement with the 
Resolution No.466/12 from the National Commission of 
Research Ethics. The data were collected after obtaining 
a favorable Legal Opinion No.754.462.
RESULTS AND DISCUSSION
There was a predominance of male patients (65%), within 
the age group from 44 to 56 years old (31.4%), with a weight 
range between 56 and 74 kg (53.6%), the most prevalent 
underlying disease being undetermined (64.1%), hemodialy-
sis time between one and two years (35.8%), and the majority 
presenting a reactive panel in both classes of less than 10%, 
class I (69.4%) and class II (81%), and most recipients had 
a deceased donor transplant (97.3%).
It was evidenced that the majority of patients after renal 
transplantation did not have DSA (66.3%), Delayed Graft 
Function (DGF) (65.3%), cellular rejection (95.0%) and 
humoral rejection (91.3%), as well as complications (71.3%). 
In relation to the serum creatinine value, a constant decline 
was observed from the first week after renal transplantation, 
but only after the third month, the majority (55%) had a 
result lower than 1.3 mg/dL, constituting the threshold of 
normality (Table 01). 
Table 01 - Distribution of renal transplant recipient according to post-
-transplant characteristics. Fortaleza city, Ceará State, 2017. n = 3
Note: 1Preformed antibody against the donor.
Spearman’s correlation showed a statistically significant 
relationship between DSA and DGF (p<0.04) (Figure 01). 
Figure 01 - Correlation between the DSA and DGF (Spearman’s correlation 
significance test).
Pearson’s correlation showed a statistically significant 
difference between cellular rejection and Panel-Reactive 
Antibody (PRA) class I (p<0.05). The correlation showed 
significant results between humoral rejection with both 
reactive panel classes, PRA I (p=0.037) and PRA II (p=0.035). 
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Figure 02 - Correlation between cellular rejection and PRA class I and 
class II (Pearson’s correlation significance test). Fortaleza city, Ceará State, 
2017. n = 300 
Considering the Figure 03 and through the Pearson’s 
correlation, it is possible to reject the null hypothesis that there 
is no correlation between the variables, since the p-value is 
less than 0.001 and concludes in favor of the alternative hypo-
thesis (p≠0) that there is a correlation. This result confirms 
the relationship between the duration of hospitalization and 
Delayed Graft Function (DGF), showing that as hospitaliza-
tion time decreases the DGF rate also tends to do the same.
Concerning the Figure 04, Pearson’s correlation showed a 
statistically significant result between HLA and MISMATCH 
(p<0.01). 
Figure 04 - Correlation between hospitalization time and graft dysfunction 
rate - DGF (Pearson’s correlation significance test). Fortaleza city, Ceará 
State, 2017. n = 300
The clinical and immunological characteristics of the 
renal graft function of the recipients of a reference hospital in 
renal transplantation were analyzed. Regarding the evaluation 
of reactivity against panel class I was of 209 (69.4%) <10% 
and that of class II presented 243 (81%) <10%, patients. The 
Panel-Reactive Antibody (PRA) test indicates the degree of 
HLA sensitization of the organ transplant recipient to the 
population of potential donors.12 This panel is selected to 
represent the distribution of HLA antigens from the popu-
lation and therefore the positivity against this panel reflects 
the reactivity against the population.13
Thus, the degrees of sensitization of a receptor will be 
considered sensitized when the reactivity is below 10%, sen-
sitized when 10-50% and hypersensitized when the reactivity 
is above 50%. This definition may vary from center to center, 
and in some places, it is defined as hypersensitizing the one 
that reacts with more than 70 or 80% of panel cells.13
The PRA has great importance in the induction of immu-
nosuppression and in the clinical follow-up of the transplan-
ted patient, since guided by the PRA dosage, the physician 
decides for a more powerful immunosuppressant or in a 
larger dose. Moreover, PRA discharge is a good indication 
of the risk of chronic rejection by DSA once again produced 
in a patient previously with a low PRA dose.14
Anti-HLA or DSA preformed antibody was found to 
be 66.3% not at risk for rejection. In contrast, 33.7% had 
preformed antibody for rejection. Regarding the prognosis 
of transplanted patients, the results indicate that a large part 
of implanted grafts did not present any dysfunction.15
The study presented a statistically significant relationship 
between DSA and graft dysfunction (p<0.05), in order to 
express that the presence of DSA has a strong influence on 
renal graft dysfunction. A study5 addresses that the graft can 
be assayed by specific antibodies (DSA) against the donor’s 
HLA produced by the recipient. These antibodies may be 
present in the recipient prior to transplantation, and thus, 
rejection may occur within the first few days or weeks after 
transplantation and may be produced later in the transplant 
period, and thus rejection occurs in a progressive and chro-
nic manner, culminating with a new chronic renal disease.
Renal transplantation is currently the therapy of choice 
for patients with end-stage renal disease. Nonetheless, a 
considerable number of grafts are still lost due to acute and 
chronic rejection. There is evidence that humoral as well 
as cellular mechanisms are involved in rejection episodes. 
This leads us to believe that, although renal transplantation 
is the best treatment for end-stage renal disease, if there 
are no technologies in the detection of these antibodies the 
receptor may be being exposed to serious risks of triggering 
rejection process.16,17
Considering the graft dysfunction (DGF), it was observed 
that the majority of the patients did not present problems with 
the development of the transplanted graft function. DGF is 
defined as the need to undergo dialysis within the first week 
after transplantation. It is a condition closely associated with 
the morbidity and significant economic burden of procedures 
necessary for the diagnosis and/or treatment of rejection 
and the long-term high rates of graft failure and mortality.18
There was a significant relationship between the length of 
hospital stay and renal graft dysfunction (p<0.01), demons-
trating that the longer the hospital stay plus the risk of graft 
dysfunction, the patient may present, a result corroborated 
in the literature.19
The study demonstrated a significant reduction in rejec-
tion rates, as the literature bring changes in detection and 
treatment directly contributing to this reduction. It is worth 
noting that a statistically significant relationship between 
cellular rejection and PRA class I (p<0.05) and between 
humoral rejection and PRA class I and class II (p<0.05) was 
evidenced.
In clinical practice, the main signs and symptoms that 
characterize the rejection are fever, systemic arterial hyper-
tension, increased volume and pain on the graft, decrease in 
urinary volume and increase in the value of serum creatinine 
with no other explanation for the ascent.20
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Early diagnosis of acute rejection is crucial for graft func-
tion and survival, which requires the care team, especially nur-
sing, to critically evaluate patients in the search for signs and 
symptoms for intervention in a quick and efficient manner.21
Regarding the HLA immunological characteristics, 46% 
of the patients had an HLA A compatibility, 47% had two 
compatibilities in HLA B and 52.3% had one in HLA DR. 
With regards to the MISMATCH, 26.3% of recipients pre-
sented three incompatibilities. The study demonstrated a 
significant relationship between HLA A, B, and DR, and 
MISMATCH (p<0.01).
Class I HLAs are basically responsible for the signaling to 
the immune system of the internal state of the cell’s protein 
machinery, among them the HLA A, B, C antigens. Class II 
HLAs are present in antigen-presenting cells of the defense 
system, notably HLA DR, DQ, and DP.22
Some factors contribute to a greater risk of developing 
graft immune rejection, such as situations in which the orga-
nism is exposed to extraneous HLA, such as in blood trans-
fusions and gestations, the greater the chance of producing 
a DSA, in other words, an antibody that can attach to the 
donor’s HLA.23
Nursing and all interdisciplinary teams play a key role in 
the care and monitoring of patients with chronic renal disease 
in the post-renal transplantation and should be performed 
in a coherent, responsible, humanized and directed to their 
singularity, based on scientific research, to ensure the best 
service. It is worth mentioning that this study contributes to 
the expansion of the knowledge of primary care professio-
nals, in order to better follow-up on patients with chronic 
diseases, mainly in adherence to treatment, lifestyle change 
and early detection of complications, such as chronic renal 
disease (by calculating the filtration rate of all patients with 
hypertension and diabetes).
This study has limitations. It is worth noting that this is 
a cross-sectional study, which by the design itself does not 
allow a follow-up of the subjects, which would allow the 
identification of risk and/or protection factors. Further-
more, this is a documentary research, then predisposed to 
information bias. 
CONCLUSIONS
Male participants within the age group from 44 to 56 
have predominated. Most had no risk of rejection, but had 
graft dysfunction, rescue therapy complications, cellular and 
humoral rejection, and infections. The time of hospitalization 
was 10 to 20 days, demonstrating a reduction in rejection 
rates. Regarding the creatinine, in the first week there was a 
decay and in the sixth month, the creatinine result was lower 
than 1.3 mg/dL, this result means satisfactory post-transplant 
clinical evolution.
Hence, the need for a critical and individualized follow-up 
of the transplanted patient by the professionals to ensure 
the long-term transplantation success, then guaranteeing 
that they return their activities with sufficient knowledge 
to maintain the graft and with self-care skills, enabling an 
adequate lifestyle and safety for professionals. 
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